Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.294, 2001-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB
Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. :
Access to resources
Recommend
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
Isoniazid programme to prevent TB cost effective in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Isoniazid limits TB incidence and mortality in children with HIV
Inpharma, Vol. 1, Iss. 1564, 2006-01 ,pp. :
Isoniazid programme to prevent TB cost effective in the US
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :